7 小时
News Medical on MSNNew UVA clinical trial explores AI-powered insulin delivery for better diabetes careFor people living with Type 1 Diabetes, keeping blood sugar levels in check is a constant challenge. A new clinical trial at ...
For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to ...
(NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically ... the addition of a mealtime bolus of a rapid acting GLP ...
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
It’s a chronic condition in which your body doesn’t use insulin properly. This causes sugar to build up in your blood, leading to other health problems over the long term. The main goal of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果